Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent expiration for Gilead Sciences drug GENVOYA appeared fi…
New patent expiration for Gilead Sciences drug GENVOYA Read Post »
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. It is available from two suppliers. There are nine patents…
The post New patent expiration for Gilead Sciences drug ATRIPLA appeared fi…
New patent expiration for Gilead Sciences drug ATRIPLA Read Post »
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are twelve…
The post New patent expiration for Gilead Sciences drug COMPLERA appeared f…
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Annual Drug Patent Expirations for ZEJULA Zejula is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Glaxosmithkline drug ZEJULA appeared first …
Annual Drug Patent Expirations for XYWAV Xywav is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent for JAZZ drug XYWAV appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug. Drug patent…
The post New patent for Alnylam Pharms drug ONPATTRO appeared firs…
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Bulgaria? Read Post »
This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug …
Which pharmaceutical companies have the most drug patents in Netherlands? Read Post »
COMPLERA (emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate) Gilead sciences inc Patent: 6,703,396 Expiration: Sep 9, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Pat…
Drug Patent Expirations for the Week of September 5, 2021 Read Post »
Get new actionable insights and updates from BiotechBlog
